Collegium Pharmaceutical, Inc.NASDAQ: COLL

Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024

· Issued by Collegium Pharmaceutical, Inc. via GlobeNewswire

STOUGHTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.

Conference Call InformationTo access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q2 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.

About Collegium Pharmaceutical, Inc.Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contact: Christopher James, M.D.Vice President, Investor Relations[email protected]

Media Contact:Marissa SamuelsVice President, Corporate Communications[email protected]

Primary Logo

Source: Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. on 6ix

Story so far

Earlier from Collegium Pharmaceutical

Later from Collegium Pharmaceutical

All Collegium Pharmaceutical news releases